Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L1NF
|
||||
| Former ID |
DIB007824
|
||||
| Drug Name |
D-420720
|
||||
| Synonyms |
Dipeptidyl peptidase inhibitor (diabetes), Development Centre for Biotechnology
|
||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [1] | ||
| Company |
Development Centre for Biotechnology
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C(#N)[C@@H]1CCCN1C(=O)CNCCNS(=O)(=O)c1ccc(cc1)F
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1612). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.